| Market Cap | ₹70,355Cr |
| ROE | 9.77% |
| P/E Ratio(TTM) | 20.19 |
| EPS(TTM) | 60.00 |
| P/B Ratio | 2.01 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.40 |
| Book Value | 603.32 |
| Debt to Equity | 0.22 |
| Face Value | 1 |
| Managing Director | K. Nithyananda Reddy |
| Founded | 1986 |
| NSE Symbol | AUROPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.39 | ||
| Cipla | NA (0.00%) | 24.09 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.57 | ||
| Lupin | NA (0.00%) | 22.63 |